A Study of Galcanezumab in Participants With Chronic Cluster Headache

Clinical trial NCT02438826 · COMPLETED

Trial details

NCT number: NCT02438826
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Cluster Headache

Start date: 2015-06-18
Primary completion: 2018-03-27
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.